** Shares of Pine Labs PINL.NS up 2.8% at 179.5 rupees
** UBS initiates coverage on fintech platform with "Buy" and a target price of 250 rupees, implying an upside of 43% from stock's last close
** Brokerage says Pine Labs maintains a strong large-enterprise franchise with a durable moat driven by scale and deep integration with banks, OEMs, and merchants
** UBS says as Pine Labs' point-of-sale business has transitioned from hyper growth to industry aligned growth, its focus has shifted to monetising existing base
** Adds incremental growth to come from EMI financing and deeper penetration into non-electronics consumer categories
** Estimates revenue growth to sustain at an estimated ~20% CAGR over FY2026–FY2028, and says the current ~45% valuation discount to Paytm looks unjustified given Pine Labs' stronger profitability and improving earnings quality
** YTD, stock down 25%
(Reporting by Mridula Kumar in Bengaluru)
((Mridula.Kumar@thomsonreuters.com;))